
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/base_style-CPPDhfna.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-BepKMsUl.js"></script>

  <link rel="stylesheet" href="/static/assets/article_style-DUfI1jZp.css" />
<link rel="stylesheet" href="/static/assets/style-BOrsu84o.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-D3wJHomh.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Visualization of FDA Adverse Drug Reaction Reports: Development and Usability Study of the VisDrugs Web Server - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="CFBE244A930B085300244A0029C7999D.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="formative">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12312990/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="JMIR Formative Research">
<meta name="citation_title" content="Visualization of FDA Adverse Drug Reaction Reports: Development and Usability Study of the VisDrugs Web Server">
<meta name="citation_author" content="Renjun Yang">
<meta name="citation_author_institution" content="State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, 18 Shuangqing Road, Haidian District, Beijing, 100085, China, 86 01062849096">
<meta name="citation_author_institution" content="College of Resources and Environment, University of Chinese Academy of Sciences, Beijing, China">
<meta name="citation_author" content="Nuoya Yin">
<meta name="citation_author_institution" content="State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, 18 Shuangqing Road, Haidian District, Beijing, 100085, China, 86 01062849096">
<meta name="citation_author_institution" content="College of Resources and Environment, University of Chinese Academy of Sciences, Beijing, China">
<meta name="citation_author" content="Yang Zhang">
<meta name="citation_author_institution" content="Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China">
<meta name="citation_author" content="Francesco Faiola">
<meta name="citation_author_institution" content="State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, 18 Shuangqing Road, Haidian District, Beijing, 100085, China, 86 01062849096">
<meta name="citation_author_institution" content="College of Resources and Environment, University of Chinese Academy of Sciences, Beijing, China">
<meta name="citation_publication_date" content="2025 Jul 31">
<meta name="citation_volume" content="9">
<meta name="citation_firstpage" content="e71519">
<meta name="citation_doi" content="10.2196/71519">
<meta name="citation_pmid" content="40743475">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12312990/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12312990/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12312990/pdf/formative-v9-e71519.pdf">
<meta name="description" content="Adverse drug reactions (ADRs) are a major concern in drug safety, and the FDA Adverse Event Reporting System (FAERS) provides valuable ADR data. However, analyzing FAERS data is complex and requires bioinformatics expertise. Despite the vast amount ...">
<meta name="og:title" content="Visualization of FDA Adverse Drug Reaction Reports: Development and Usability Study of the VisDrugs Web Server">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Adverse drug reactions (ADRs) are a major concern in drug safety, and the FDA Adverse Event Reporting System (FAERS) provides valuable ADR data. However, analyzing FAERS data is complex and requires bioinformatics expertise. Despite the vast amount ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12312990/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12312990">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.2196/71519"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/formative-v9-e71519.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12312990%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12312990/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12312990/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12312990/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-formative.png" alt="JMIR Formative Research logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to JMIR Formative Research" title="Link to JMIR Formative Research" shape="default" href="https://formative.jmir.org/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">JMIR Form Res</button></div>. 2025 Jul 31;9:e71519. doi: <a href="https://doi.org/10.2196/71519" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.2196/71519</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22JMIR%20Form%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22JMIR%20Form%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22JMIR%20Form%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22JMIR%20Form%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Visualization of FDA Adverse Drug Reaction Reports: Development and Usability Study of the VisDrugs Web Server</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Renjun Yang</span></a><div hidden="hidden" id="id1">
<h3>
<span class="name western">Renjun Yang</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>1</sup>State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, 18 Shuangqing Road, Haidian District, Beijing, 100085, China, 86 01062849096</div>
<div class="p">
<sup>2</sup>College of Resources and Environment, University of Chinese Academy of Sciences, Beijing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Renjun Yang</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yin%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Nuoya Yin</span></a><div hidden="hidden" id="id2">
<h3>
<span class="name western">Nuoya Yin</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>1</sup>State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, 18 Shuangqing Road, Haidian District, Beijing, 100085, China, 86 01062849096</div>
<div class="p">
<sup>2</sup>College of Resources and Environment, University of Chinese Academy of Sciences, Beijing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yin%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nuoya Yin</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Yang Zhang</span></a><div hidden="hidden" id="id3">
<h3>
<span class="name western">Yang Zhang</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>3</sup>Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yang Zhang</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Faiola%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Francesco Faiola</span></a><div hidden="hidden" id="id4">
<h3>
<span class="name western">Francesco Faiola</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>1</sup>State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, 18 Shuangqing Road, Haidian District, Beijing, 100085, China, 86 01062849096</div>
<div class="p">
<sup>2</sup>College of Resources and Environment, University of Chinese Academy of Sciences, Beijing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Faiola%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Francesco Faiola</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>
</div>
<div class="cg p">Editor: <span class="name western">Amaryllis Mavragani</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, 18 Shuangqing Road, Haidian District, Beijing, 100085, China, 86 01062849096</div>
<div id="aff2">
<sup>2</sup>College of Resources and Environment, University of Chinese Academy of Sciences, Beijing, China</div>
<div id="aff3">
<sup>3</sup>Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China</div>
<div class="author-notes p"><div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline">Francesco Faiola, PhD, State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, 18 Shuangqing Road, Haidian District, Beijing, 100085, China, 86 01062849096; <span>faiola@rcees.ac.cn</span></p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jan 20; Revised 2025 Jun 10; Accepted 2025 Jun 12; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © Renjun Yang, Nuoya Yin, Yang Zhang, Francesco Faiola. Originally published in JMIR Formative Research (https://formative.jmir.org)</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on <a href="https://formative.jmir.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://formative.jmir.org</a>, as well as this copyright and license information must be included.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12312990  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40743475/" class="usa-link">40743475</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p>Adverse drug reactions (ADRs) are a major concern in drug safety, and the FDA Adverse Event Reporting System (FAERS) provides valuable ADR data. However, analyzing FAERS data is complex and requires bioinformatics expertise. Despite the vast amount of ADR data available, there is a lack of user-friendly tools that enable efficient visualization and comparison of ADRs for researchers and health care professionals.</p></section><section id="sec2"><h3 class="pmc_sec_title">Objective</h3>
<p>This study aimed to develop VisDrugs, a web-based platform that simplifies ADR visualization and comparison using FAERS data. The platform was designed to assist researchers and clinicians in assessing drug safety through interactive and interpretable graphical representations of ADR patterns.</p></section><section id="sec3"><h3 class="pmc_sec_title">Methods</h3>
<p>FAERS data were extracted in the American Standard Code for Information Interchange (ASCII) format, covering the period from Q3 (third quarter) 2014 to Q3 2024. About 2,700,000 reports from health care professionals, where only a single drug was implicated, were aggregated and processed using R for statistical analysis and visualization. The results are presented on a web-based platform for web-based analysis. The platform generates pie charts to visualize the most frequently reported ADRs, which are represented and analyzed using preferred terms based on the Medical Dictionary for Regulatory Activities (MedDRA) and forest plots illustrating reporting odds ratios (RORs) for these ADRs.</p></section><section id="sec4"><h3 class="pmc_sec_title">Results</h3>
<p>Using Paxlovid (COVID-19 treatment) and hydroxychloroquine (anti-malaria drug) as case studies, we benchmarked VisDrugs using reports for Paxlovid (n=16,708) and hydroxychloroquine (n=6150). Paxlovid was most frequently associated with “COVID-19” (ROR=47.26, 95% CI 45.22‐49.40) and “dysgeusia” (ROR=59.65, 95% CI 55.56‐64.03). Hydroxychloroquine showed strong associations with “retinal toxicity” (ROR=738.48, 95% CI 583.45‐934.71), “retinopathy” (ROR=412.27, 95% CI 344.73‐493.03), and “cardiotoxicity” (ROR=48.36, 95% CI 38.86‐60.19). In subgroup analyses, female patients had significantly higher risks of retinopathy (3.24-fold) and cardiomyopathy (13.82-fold) compared to male patients, while patients aged &gt;50 years had higher risks of retinopathy (4.20-fold) and cardiomyopathy (7.84-fold) compared to those ≤50 years. All differences were statistically significant (<em>z</em> test, <em>P</em>&lt;.01). The majority of findings align with existing research, thereby validating the platform’s utility. Clinical personnel have evaluated and refined the platform based on user feedback, confirming its efficacy in visualizing complex ADR data and identifying adverse effects across various drug subgroups.</p></section><section id="sec5"><h3 class="pmc_sec_title">Conclusions</h3>
<p>VisDrugs is a valuable tool for ADR analysis, offering an intuitive interface for exploring FAERS data. By visualizing and comparing ADRs, it helps researchers and health care providers assess drug safety efficiently. The platform’s demographic analysis features add insights into ADR variations by age and gender, supporting drug safety research. In the future, the website will include more subgroup or condition filtering options, offering personalized ADR analysis and comparison features to meet the diverse research needs of users.</p></section></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Adverse drug reactions (ADRs) are unintended responses that are detected in patients after the use of drugs for the prophylaxis, diagnosis, or treatment of a disease at doses normally used [<a href="#R1" class="usa-link" aria-describedby="R1">1</a>]. ADRs represent an important public health challenge, contributing to significant hospital admissions and deaths worldwide [<a href="#R2" class="usa-link" aria-describedby="R2">2</a>,<a href="#R3" class="usa-link" aria-describedby="R3">3</a>]. The US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) provides a critical database that captures reports of adverse events linked to pharmaceutical products [<a href="#R4" class="usa-link" aria-describedby="R4">4</a>,<a href="#R5" class="usa-link" aria-describedby="R5">5</a>]. With millions of reports, FAERS serves as an invaluable resource for evaluating drug safety and post-market surveillance [<a href="#R6" class="usa-link" aria-describedby="R6">6-12</a>]. FAERS is continuously updated and includes data from a wide range of sources, including health care professionals, patients, and drug manufacturers [<a href="#R13" class="usa-link" aria-describedby="R13">13</a>]. Each report in the FAERS database provides information on a specific adverse event associated with a drug, including ADR description, the drug involved, the patient’s age and sex, and other information.</p>
<p>Despite their vast potential for drug safety analysis, FAERS data present several challenges. The large record number poses a significant hurdle to traditional analysis methods. Moreover, the data are often unstructured and contain a considerable amount of noise, requiring sophisticated data-cleaning techniques [<a href="#R14" class="usa-link" aria-describedby="R14">14</a>]. For researchers to interpret these data effectively, a solid foundation in bioinformatics and statistical modeling is often required. The need for simplified, accessible tools for ADR analysis has become increasingly apparent. Although several web-based user interfaces, such as OpenVigil FDA and VigiAccess, facilitate access to FAERS data, conducting a detailed comparison of ADRs still necessitates performing calculations on the obtained data using bioinformatics methods [<a href="#R15" class="usa-link" aria-describedby="R15">15-18</a>]. Currently, there is no widely available web platform that offers an easy, interactive way to analyze FAERS data, especially for comparing the adverse effects of different drugs in a straightforward manner. This gap creates a barrier for researchers, clinicians, and policy makers who need quick insights into drug safety but lack the technical expertise to handle large-scale pharmacovigilance data.</p>
<p>In response to this challenge, we have developed the VisDrugs website, an interactive platform designed to simplify the process of analyzing drug-related adverse effects using FAERS data. The VisDrugs platform includes a comparison feature that allows users to input 2 groups of drugs and analyze the differences in their safety profiles with respect to specific adverse events. Furthermore, it conducts analyses by subgroups of age and gender to evaluate the effects of these variables on specific reactions. Visdrugs addresses a critical gap in the current landscape of drug safety analysis tools. By leveraging the extensive resources of the FAERS database and presenting them through a user-friendly interface, it enables a broader audience to engage with drug safety data.</p></section><section id="s2"><h2 class="pmc_sec_title">Methods</h2>
<section id="s2-1"><h3 class="pmc_sec_title">Website Framework</h3>
<p>The VisDrugs website is designed to provide 1-click analysis of FDA ADR data [<a href="#R19" class="usa-link" aria-describedby="R19">19</a>]. Users can easily use its features through any web browser, making it simple and convenient to use. The FDA ADR dataset on the site is updated annually in alignment with the latest updates from the FDA FAERS database.</p>
<p>VisDrugs operates on the Tencent Cloud server platform, featuring a CentOS 7.6 64-bit system with an 8-core CPU, 32 GB cache memory, 320 GB disk storage, and 22 Mbps bandwidth, supporting simultaneous web-based analyses by many researchers at the same time.</p>
<p>VisDrugs uses Java (version 8), Spring Boot, and MyBatis Plus to provide server-side API support. The visual frontend of the website is created using JavaScript, Vue (version 3), and Element Plus. Apache (version 9.0) is used as the web server, and nginx is used for load balancing. The MySQL database is used for backend storage of sequences, taxonomy, and user data.</p>
<p>The core 1-click analysis feature is powered by R language, which is a good choice for statistical analysis. The system minimizes redundant information, such as duplicated and incomplete reports, during data preprocessing, enhancing data analysis efficiency. VisDrugs provides researchers with a robust and efficient platform for FDA ADR data exploration and analysis.</p></section><section id="s2-2"><h3 class="pmc_sec_title">Data Retrieving, Preprocessing, and Visualization</h3>
<p>Data retrieval, preprocessing, and visualization were performed, as depicted in <a href="#F1" class="usa-link">Figure 1</a>. In detail, ADR data were extracted in ASCII format from the FDA database, covering the period from Q3 (third quarter) 2014 to Q1 2024. Data prior to Q3 2014 were not included mainly because they were from a time when the “DRUGyyQq.TXT” file did not contain active ingredient information for the drugs, and the data were less standardized. Starting from Q3 2014, the inclusion of drug active ingredient information and the improved data structure allowed for more accurate visualization of the results.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1.  Data preprocessing flow and interactive interface operation flowchart for the VisDrugs website. ASCII: American Standard Code for Information Interchange; FAERS: Food and Drug Administration Adverse Event Reporting System; GUI: graphical user interface.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12312990_formative-v9-e71519-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12312990/f6f9b5f53034/formative-v9-e71519-g001.jpg" loading="lazy" height="718" width="757" alt="Figure 1."></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>The data preprocessing step primarily used 3 key files: the DEMOyyQq.TXT, which contains basic case information; the REACyyQq.TXT, which includes ADR details for the patients; and the DRUGyyQq.TXT, which holds information on drug active ingredients (“Product active ingredient”) and the reported role of the drug in the adverse event (“Code for drug’s reported role in event”).</p>
<p>For the DEMOyyQq.TXT file, we filtered data over the past decade. Specifically, we selected data reported by 4 types of health care professionals (HP, health professional [HP]; physician [MD]; other health professional [OT]; and pharmacist [PH]) based on the abbreviation for the reporter’s type of occupation. We then aggregated quarterly data over the years to create a comprehensive DEMOyyQq.TXT dataset covering 2014‐2024. This dataset includes case ID, patient gender and age, and the occupation type of the reporter, which can be used for further interactive analysis features on the website. Additionally, we summarized the case data to filter relevant reports from REACyyQq.TXT and DRUGyyQq.TXT files.</p>
<p>Next, we aggregated the cases from REACyyQq.TXT reported by professionals, with the ADRs defined using preferred term (PT)–level medical terminology describing the event, using the Medical Dictionary for Regulatory Activities (MedDRA). For the DRUGyyQq.TXT file, we focused on the cases reported by professionals, extracting the active ingredients that were identified as the primary suspect drug of each report. For the aggregate files, duplicates were removed by keeping only the latest version of each case (based on the FDA’s primary ID and version number). Records missing essential information, such as the drug’s active substance name or ADR term, were excluded.</p>
<p>During visualization, the R language was used to analyze the preprocessed datasets, performing statistical calculations and generating graphs to display potential ADRs. In simpler terms, our self-developed ShinyR program performs statistical analysis on the aggregated preprocessed data and creates pie charts based on the total number of ADRs. Additionally, for drug ADR analysis, we use the commonly used method of reporting odds ratio (ROR) [<a href="#R20" class="usa-link" aria-describedby="R20">20</a>] to generate forest plots.</p>
<p>Standard MedDRA PTs were used to calculate potential ADRs, and active substances, which are standard chemical names, were applied as drug names to ensure consistency. The database will be updated yearly to incorporate the latest FAERS releases.</p></section><section id="s2-3"><h3 class="pmc_sec_title">Calculation of Reporting Odds Ratio and Statistical Significance Analysis</h3>
<p>The ROR for a selected drug compared to all other drugs was calculated as reported by Rothman et al [<a href="#R21" class="usa-link" aria-describedby="R21">21</a>]:</p>
<table class="disp-formula p" id="eqnwl1"><tr><td class="formula"><math id="M1" display="block" overflow="linebreak"><mstyle displaystyle="true" scriptlevel="0"><mrow><mrow><mi mathvariant="normal">R</mi></mrow><mrow><mi mathvariant="normal">O</mi></mrow><msub><mrow><mi mathvariant="normal">R</mi></mrow><mrow><mrow><mi mathvariant="normal">j</mi></mrow></mrow></msub><mo>=</mo><mfrac><mrow><msub><mrow><mi mathvariant="normal">N</mi></mrow><mrow><mrow><mi mathvariant="normal">A</mi></mrow><mo>,</mo><mrow><mi mathvariant="normal">j</mi></mrow></mrow></msub><mrow><mo>/</mo></mrow><msub><mrow><mi mathvariant="normal">N</mi></mrow><mrow><mrow><mi mathvariant="normal">A</mi></mrow><mo>,</mo><mi mathvariant="normal">¬</mi><mrow><mi mathvariant="normal">j</mi></mrow></mrow></msub></mrow><mrow><msub><mrow><mi mathvariant="normal">N</mi></mrow><mrow><mi mathvariant="normal">¬</mi><mrow><mi mathvariant="normal">A</mi></mrow><mo>,</mo><mrow><mi mathvariant="normal">j</mi></mrow></mrow></msub><mrow><mo>/</mo></mrow><msub><mrow><mi mathvariant="normal">N</mi></mrow><mrow><mi mathvariant="normal">¬</mi><mrow><mi mathvariant="normal">A</mi></mrow><mo>,</mo><mi mathvariant="normal">¬</mi><mrow><mi mathvariant="normal">j</mi></mrow></mrow></msub></mrow></mfrac></mrow></mstyle></math></td></tr></table>
<p>where RORj is the ROR for ADRj associated with the selected drug A. N<sub>A,j</sub> is the number of reports where drug A is associated with ADRj. NA,¬j is the number of reports where drug A is reported but without ADRj. N¬A,j is the number of reports where ADRj is reported but drug A is not involved. N¬A,¬j is the number of reports where neither drug A nor ADRj is reported.</p>
<p>The standard error of the log-transformed ROR is given by:</p>
<table class="disp-formula p" id="eqnwl2"><tr><td class="formula"><math id="M2" display="block" overflow="linebreak"><mstyle displaystyle="true" scriptlevel="0"><mrow><mrow><mi mathvariant="normal">S</mi></mrow><mrow><mi mathvariant="normal">E</mi></mrow><mrow><mo>(</mo><mrow><mrow><mi mathvariant="normal">l</mi></mrow><mrow><mi mathvariant="normal">n</mi></mrow><mrow><mi mathvariant="normal">R</mi></mrow><mrow><mi mathvariant="normal">O</mi></mrow><msub><mrow><mi mathvariant="normal">R</mi></mrow><mrow><mrow><mi mathvariant="normal">j</mi></mrow></mrow></msub></mrow><mo>)</mo></mrow><mo>=</mo><msqrt><mfrac><mn>1</mn><msub><mrow><mi mathvariant="normal">N</mi></mrow><mrow><mrow><mi mathvariant="normal">A</mi></mrow><mo>,</mo><mrow><mi mathvariant="normal">j</mi></mrow></mrow></msub></mfrac><mo>+</mo><mfrac><mn>1</mn><msub><mrow><mi mathvariant="normal">N</mi></mrow><mrow><mrow><mi mathvariant="normal">A</mi></mrow><mo>,</mo><mi mathvariant="normal">¬</mi><mrow><mi mathvariant="normal">j</mi></mrow></mrow></msub></mfrac><mo>+</mo><mfrac><mn>1</mn><msub><mrow><mi mathvariant="normal">N</mi></mrow><mrow><mi mathvariant="normal">¬</mi><mrow><mi mathvariant="normal">A</mi></mrow><mo>,</mo><mrow><mi mathvariant="normal">j</mi></mrow></mrow></msub></mfrac><mo>+</mo><mfrac><mn>1</mn><msub><mrow><mi mathvariant="normal">N</mi></mrow><mrow><mi mathvariant="normal">¬</mi><mrow><mi mathvariant="normal">A</mi></mrow><mo>,</mo><mi mathvariant="normal">¬</mi><mrow><mi mathvariant="normal">j</mi></mrow></mrow></msub></mfrac></msqrt></mrow></mstyle></math></td></tr></table>
<p>On the log scale, the CI is given by:</p>
<table class="disp-formula p" id="eqn5"><tr><td class="formula"><math id="M3" display="block" overflow="linebreak"><mstyle displaystyle="true" scriptlevel="0"><mrow><mi>l</mi><mi>n</mi><mi>R</mi><mi>O</mi><mi>R</mi><mi>j</mi><mo>±</mo><mn>1.96</mn><mo>×</mo><mi>S</mi><mi>E</mi><mo stretchy="false">(</mo><mi>l</mi><mi>n</mi><mi>R</mi><mi>O</mi><mi>R</mi><mi>j</mi><mo stretchy="false">)</mo></mrow></mstyle></math></td></tr></table>
<p>To obtain the final CI for ROR, the following equation is used:</p>
<table class="disp-formula p" id="eqnwl3"><tr><td class="formula"><math id="M4" display="block" overflow="linebreak"><mstyle displaystyle="true" scriptlevel="0"><mrow><mi>C</mi><msub><mi>I</mi><mrow><mi>R</mi><mi>O</mi><mi>R</mi></mrow></msub><mo>=</mo><mrow><mo>(</mo><mrow><msup><mi>e</mi><mrow><mi>l</mi><mi>n</mi><mi>R</mi><mi>O</mi><msub><mi>R</mi><mrow><mi>j</mi></mrow></msub><mo>−</mo><mn>1.96</mn><mo>×</mo><mi>S</mi><mi>E</mi><mrow><mo>(</mo><mrow><mi>l</mi><mi>n</mi><mi>R</mi><mi>O</mi><msub><mi>R</mi><mrow><mi>j</mi></mrow></msub></mrow><mo>)</mo></mrow></mrow></msup><mo>,</mo><msup><mi>e</mi><mrow><mi>l</mi><mi>n</mi><mi>R</mi><mi>O</mi><msub><mi>R</mi><mrow><mi>j</mi></mrow></msub><mo>+</mo><mn>1.96</mn><mo>×</mo><mi>S</mi><mi>E</mi><mrow><mo>(</mo><mrow><mi>l</mi><mi>n</mi><mi>R</mi><mi>O</mi><msub><mi>R</mi><mrow><mi>j</mi></mrow></msub></mrow><mo>)</mo></mrow></mrow></msup></mrow><mo>)</mo></mrow></mrow></mstyle></math></td></tr></table>
<p>In the forest plot, an ROR value was considered statistically significant if the lower bound of its log2-transformed 95% CI was greater than zero. To evaluate whether the RORs differed significantly between 2 subgroups (eg, age or sex), we applied a <em>z</em> test based on the log-transformed RORs and their standard errors.</p>
<p>The z statistic was calculated as:</p>
<table class="disp-formula p" id="eqnwl4"><tr><td class="formula"><math id="M5" display="block" alttext="z=\frac{ln\left (ROR_{1}\right)-ln\left (ROR_{2}\right)}{\sqrt{SE_{1}^{2}+SE_{2}^{2}}}" overflow="linebreak"><mi>z</mi><mo>=</mo><mfrac><mrow><mi>l</mi><mi>n</mi><mo>(</mo><msub><mrow><mi>R</mi><mi>O</mi><mi>R</mi></mrow><mrow><mn>1</mn></mrow></msub><mo>)</mo><mo>-</mo><mi>l</mi><mi>n</mi><mo>(</mo><msub><mrow><mi>R</mi><mi>O</mi><mi>R</mi></mrow><mrow><mn>2</mn></mrow></msub><mo>)</mo></mrow><mrow><msqrt><msubsup><mrow><mi>S</mi><mi>E</mi></mrow><mrow><mn>1</mn></mrow><mrow><mn>2</mn></mrow></msubsup><mo>+</mo><msubsup><mrow><mi>S</mi><mi>E</mi></mrow><mrow><mn>2</mn></mrow><mrow><mn>2</mn></mrow></msubsup></msqrt></mrow></mfrac></math></td></tr></table>
<p>The resulting 2-sided <em>P</em> value for the <em>z</em> test was computed as:</p>
<table class="disp-formula p" id="eqn6"><tr><td class="formula"><math id="M6" display="block" overflow="linebreak"><mstyle displaystyle="true" scriptlevel="0"><mrow><mi>p</mi><mo>=</mo><mn>2</mn><mo>×</mo><mo stretchy="false">(</mo><mn>1</mn><mo>−</mo><mrow><mo>Φ</mo></mrow><mo stretchy="false">(</mo><mrow><mo stretchy="false">|</mo></mrow><mi>z</mi><mrow><mo stretchy="false">|</mo></mrow><mo stretchy="false">)</mo><mo stretchy="false">)</mo></mrow></mstyle></math></td></tr></table>
<p>where Φ denotes the cumulative distribution function of the standard normal distribution. A difference of at least 1.5-fold in ROR values between the 2 subgroups, combined with a <em>P</em> value&lt;.05, was considered statistically significant.</p>
<p>To ensure comprehensive reporting and transparency, a detailed checklist following the Software/Tools Papers guidelines is provided (see <a href="#SCHL1" class="usa-link">Checklist 1</a>).</p></section><section id="s2-4"><h3 class="pmc_sec_title">Ethical Considerations</h3>
<p>This study involved secondary analysis of publicly available, deidentified data from the US FDA FAERS. No identifiable personal information was accessed or used. As the dataset is anonymized and contains no patient-level identifiers, this study was exempt from institutional review board approval in accordance with local regulations and ethical guidelines. The analysis complied with all applicable data use policies and ethical standards for research involving publicly available datasets.</p></section></section><section id="s3"><h2 class="pmc_sec_title">Results</h2>
<section id="s3-1"><h3 class="pmc_sec_title">Analysis for Most Potential Reactions of Target Drugs</h3>
<p>The VisDrugs website offers 2 selectable methods for analyzing ADRs. In the “Most Potential Reactions of Target Drugs” mode, users only need to perform 2 actions on the graphical user interface to view the ADRs most relevant to drug-of-interest’s usage: (1) type to search for the active ingredient name of the drug-of-interest. The relevant active ingredient will appear in the search selection box, where users can choose either a single active ingredient or multiple active ingredients as a whole for analysis and (2) name the target drug group and click “submit.”</p>
<p>After submitting, the webpage will generate two charts: (1) a pie chart showing the top 15 ADRs of the selected drug and (2) a forest plot comparing the top 15 ADRs from the pie chart that shows whether they are more likely caused by the selected drug or other drugs. Disproportionality analysis, which estimates the ROR, is used in the forest plot for detecting spontaneous signals, establishing the statistical link between drug exposure and a particular ADR [<a href="#R20" class="usa-link" aria-describedby="R20">20</a>]. The ROR, calculated using the case or non-case method, represents the odds ratio of a specific ADR relative to all other ADRs for each drug [<a href="#R21" class="usa-link" aria-describedby="R21">21</a>].</p>
<p>Additionally, four download buttons will be provided for users to download images or raw data: (1) high-definition pie chart of the drug’s ADRs; (2) high-definition forest plot of the drug’s ADRs; (3) an Excel table of drug ADR frequency statistics (all reactions); and (4) an Excel table of the raw data for the forest plot.</p>
<p>It is important to note that when typing to search for a drug, users should enter the active ingredient name of the drug. Active ingredients are more standardized than drug names and help prevent incorrect matches. Users must also select the relevant active ingredient from the list, as only selected drugs indicate that the site includes related data for that drug. Furthermore, the website provides a user guide where users can click to view detailed instructions on what information should be entered in each section and how to interpret the results.</p>
<p>Overall, the “Most Potential Reactions of Target Drugs” analysis function on the website provides a highly convenient method for analyzing the most common ADRs of drugs.</p></section><section id="s3-2"><h3 class="pmc_sec_title">Application Examples: Analyzing the Most Commonly Reported ADRs of Paxlovid and Hydroxychloroquine</h3>
<p>We use Paxlovid, a special antiviral drug for COVID-19, and the antimalarial drug hydroxychloroquine, which was initially considered to offer therapeutic benefits in COVID-19 patients [<a href="#R22" class="usa-link" aria-describedby="R22">22</a>], but withdrew from use in COVID-19 treatment by FDA in June 2020 [<a href="#R23" class="usa-link" aria-describedby="R23">23</a>], as examples to demonstrate the “Most Potential Reactions of Target Drugs” feature on the website. Paxlovid contains 2 active ingredients: Nirmatrelvir and Ritonavir [<a href="#R24" class="usa-link" aria-describedby="R24">24-26</a>]. In this example, given the focus on Paxlovid, the analysis was conducted using the active ingredients “NIRMATRELVIR/RITONAVIR”, which represent a drug comprising both components, to facilitate a comprehensive examination of potential synergistic adverse effects (see Figure S1 in <a href="#SAP1" class="usa-link">Multimedia Appendix 1</a> for detailed tool settings). For hydroxychloroquine, both “hydroxychloroquine” and its sulfate form, “hydroxychloroquine sulfate”, were applied for analysis (see Figure S2 in <a href="#SAP1" class="usa-link">Multimedia Appendix 1</a> for detailed tool settings).</p>
<p>For Paxlovid, from the pie chart and forest plot (<a href="#F2" class="usa-link">Figure 2A and C</a>), we observe that in the top 15 ADRs, 12 ADRs occur more frequently in Paxlovid compared to other drugs. Patients using Paxlovid are more frequently reported to experience disease recurrence, dysgeusia (COVID-19), and taste disorder (<a href="#F2" class="usa-link">Figure 2C</a>). In fact, the presence of COVID-19 is consistent with Paxlovid’s indication, and disease recurrence is a very common phenomenon in COVID-19 cases [<a href="#R27" class="usa-link" aria-describedby="R27">27</a>,<a href="#R28" class="usa-link" aria-describedby="R28">28</a>]. Dysgeusia and taste disorders are also the most common ADRs associated with COVID-19. Other reported ADRs, such as cough, vomiting, and headache, are also commonly associated with COVID-19, indicating that the ADR reports for Paxlovid can be viewed as part of the disease symptoms to its indication, COVID-19 [<a href="#R29" class="usa-link" aria-describedby="R29">29</a>].</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2. Most relevant adverse drug reactions (ADRs) associated with Paxlovid and hydroxychloroquine based on FAERS (FDA Adverse Event Reporting System) reports analyzed using the VisDrugs system. Pie charts show the top 15 ADRs reported for Paxlovid (<strong>A</strong>) and hydroxychloroquine (<strong>B</strong>). Forest plots comparing the top 15 ADRs of Paxlovid (<strong>C</strong>) and hydroxychloroquine (<strong>D</strong>) with those of all other drugs. The black diamonds indicate the log2-transformed reporting odds ratios (RORs), and the green lines represent the corresponding log2-transformed 95% CIs. TR: target reaction.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12312990/82276e3c2d4f/formative-v9-e71519-g002.jpg" loading="lazy" height="733" width="611" alt="Figure 2."></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>This situation in the ADR analysis may occur because health care professionals may report both disease symptoms and drug-related side effects as ADRs when submitting data to FAERS. This highlights the importance of considering the drug’s indication when analyzing ADRs in FAERS. When a drug’s major ADRs align with its intended indication, it might be reasonable to conclude that the drug does not cause additional severe ADRs. Furthermore, the analysis results above are very similar to those obtained by Li et al [<a href="#R29" class="usa-link" aria-describedby="R29">29</a>], who used FAERS data to analyze Paxlovid-related ADRs from health care professionals, confirming the feasibility of the analysis method provided by this website.</p>
<p>For hydroxychloroquine, we observe that the most frequently reported ADRs include retinal issues (such as retinopathy, maculopathy, visual field defects, and retinal toxicity), cardiac issues (such as prolonged QT on electrocardiogram and cardiomyopathy), and hypokalemia, which may lead to arrhythmia (<a href="#F2" class="usa-link">Figure 2B</a>). The forest plot also shows that hydroxychloroquine is indeed more likely to cause these ADRs compared to other drugs (<a href="#F2" class="usa-link">Figure 2D</a>).</p>
<p>This finding aligns with existing research, as hydroxychloroquine has been shown in epidemiological studies to pose a potential risk for retinopathy [<a href="#R30" class="usa-link" aria-describedby="R30">30</a>,<a href="#R31" class="usa-link" aria-describedby="R31">31</a>]. Additionally, cardiac disorders are a significant side effect of hydroxychloroquine. It has been reported that plenty of severely ill COVID-19 patients treated with hydroxychloroquine experienced a corrected QT interval increase [<a href="#R32" class="usa-link" aria-describedby="R32">32</a>,<a href="#R33" class="usa-link" aria-describedby="R33">33</a>]. In addition, case reports have shown that hydroxychloroquine overdose can lead to hypokalemia [<a href="#R34" class="usa-link" aria-describedby="R34">34</a>]. Given that FAERS analysis has highlighted the risk of hypokalemia associated with hydroxychloroquine, this adverse effect warrants closer attention.</p>
<p>Interestingly, hydroxychloroquine was originally an antimalarial drug, but the top ADRs seem not related to malaria, indicating severity of retinal and cardiac issues caused by hydroxychloroquine are of much greater concern to health care providers than any potential ADRs related to malaria itself.</p></section><section id="s3-3"><h3 class="pmc_sec_title">Reaction Comparison Between Drugs</h3>
<p>The “Reaction Comparison Between Drugs” mode allows users to compare the occurrence of specific ADRs between 2 groups of drugs. The following steps are required to perform this analysis: (1) input and select the active ingredient name of the target drug; (2) leave “Control Drugs” as “OTHER DRUGS” to compare the target drug with all other drugs, or delete “OTHER DRUGS” and input the active ingredient name of a specific control drug to compare the ADRs of 2 particular drugs; (3) input and select the ADR names of interest; (4) choose whether to group the analysis by age and gender, or conduct the analysis without grouping; and (5) name both the target drug group and the control drug group, then click “Submit.”</p>
<p>This analysis method allows for a focused comparison of specific ADRs between drugs of the same class, facilitating researchers in identifying safer options within the same drug category.</p></section><section id="s3-4"><h3 class="pmc_sec_title">Application Example: Comparing ADRs of Hydroxychloroquine and Paxlovid</h3>
<p>In this example, the user inputs “hydroxychloroquine” in the target drug field, selecting both “hydroxychloroquine” and “hydroxychloroquine sulfate”. In the control drug field, we use “NIRMATRELVIR/RITONAVIR”. The target reaction field is filled with the most potential ADRs of hydroxychloroquine found in <a href="#F2" class="usa-link">Figure 2</a>, including retinal toxicity (retinopathy, maculopathy, and visual field defect), cardiac ADRs (cardiomyopathy and electrocardiogram QT prolongation), and hypokalemia, which may lead to arrhythmias.</p>
<p>In the mode without subgroup analysis (<a href="#F3" class="usa-link">Figure 3A</a>), upon submitting the data, the results in the forest plot show that compared to the control drug Paxlovid, hydroxychloroquine indeed tends to cause the aforementioned 7 ADRs (<a href="#F3" class="usa-link">Figure 3B</a>). Conversely, the frequency of these reactions with Paxlovid is extremely low. Among 15,850 cases of Paxlovid use, only a limited number of cases reported related ADRs, suggesting that Paxlovid induces less retinal toxicity, cardiomyopathy, or hypokalemia compared to hydroxychloroquine.</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Figure 3. Comparison of retinopathy, cardiomyopathy, and hypokalemia potential of hydroxychloroquine and Paxlovid. (<strong>A</strong>) User input example under the Reaction Comparison Between Drugs model. (<strong>B</strong>) Forest plot comparing the adverse drug reactions (ADRs) of interest between hydroxychloroquine and Paxlovid groups. The black diamonds indicate the log2-transformed reporting odds ratios (RORs), and the green lines represent the corresponding log2-transformed 95% CIs. TR: target reaction.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12312990/41e6c3989ed6/formative-v9-e71519-g003.jpg" loading="lazy" height="652" width="733" alt="Figure 3."></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="s3-5"><h3 class="pmc_sec_title">Application Example: Gender Difference Analysis of Hydroxychloroquine ADRs</h3>
<p>In this example, the user inputs “hydroxychloroquine” in the target drug field, selecting both “hydroxychloroquine” and “hydroxychloroquine sulfate”. In the control drug field, “OTHER DRUGS” is retained for comparison with ADRs from all other drugs. The analysis focuses on retinal ADRs (such as retinal toxicity, retinopathy, maculopathy, and visual field defects), cardiac ADRs (including cardiomyopathy and electrocardiogram QT prolongation), and hypokalemia, which may lead to arrhythmias. The data is submitted with a gender-based subgroup analysis.</p>
<p>The results in <a href="#F4" class="usa-link">Figure 4</a> indicate that “hydroxychloroquine” is more likely to cause retinal toxicity in female patients, including retinal toxicity (71.44-fold; <em>z</em> test <em><em>P</em></em>
<em>value </em><em>&lt;</em><em>.0</em>01 than in male patients) and retinopathy (3.24-fold; <em>z</em> test <em><em>P</em></em>
<em>value </em><em>=.001 </em>than in male patients). This aligns with an epidemiological study by Jorge et al [<a href="#R35" class="usa-link" aria-describedby="R35">35</a>] in 2024, which found that female sex was associated with a higher risk of these adverse effects. Additionally, the results show that “hydroxychloroquine” is more likely to cause cardiomyopathy in female patients (13.82-fold; <em>z</em> test <em><em>P</em></em>
<em>value </em><em>&lt;</em><em>.0</em>01 than male). This finding contrasts with a study by Goldman et al [<a href="#R36" class="usa-link" aria-describedby="R36">36</a>] in 2022, which analyzed the FAERS database data from 07/2014 to 09/2019 and did not observe a gender-based difference in cardiomyopathy risk. The discrepancy may be due to their inclusion of reports from non–health care professionals, which could be less accurate. Alternatively, the increase in cardiovascular disease in women during the COVID-19 pandemic, or the possibility that “hydroxychloroquine” may indeed have a greater propensity to cause heart disease in women, could explain this difference. Notably, in the ADRs associated with Paxlovid, we did not observe any cardiac-related ADRs. Additionally, evidence indicates that COVID-19 is more likely to cause viral myocarditis or pericarditis in men [<a href="#R37" class="usa-link" aria-describedby="R37">37</a>]. Therefore, we speculate that hydroxychloroquine may have a higher risk of causing heart disease in women, which is a noteworthy finding from this study.</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Figure 4. Evaluation of the gender-specific risk of hydroxychloroquine on retinopathy, cardiomyopathy, and hypokalemia. Shown is the forest plot comparing the adverse drug reactions (ADRs) of interest between hydroxychloroquine and other drug groups, subgrouped by gender. The black diamonds indicate the log2-transformed reporting odds ratios (RORs), and the green lines represent the corresponding log2-transformed 95% CIs. TR: target reaction.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12312990/b6141a12cebd/formative-v9-e71519-g004.jpg" loading="lazy" height="438" width="733" alt="Figure 4."></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>In addition, we conducted a gender-based subgroup analysis of the top 10 most frequently reported ADRs potentially representing ADRs for Paxlovid. The ROR differences between male and female subgroups for these ADRs were all less than 1.5 times (Figure S3 in <a href="#SAP1" class="usa-link">Multimedia Appendix 1</a>), suggesting that sex differences have minimal impact on the occurrence of these ADRs.</p></section><section id="s3-6"><h3 class="pmc_sec_title">Application Example: Age Difference Analysis of Hydroxychloroquine ADRs</h3>
<p>This example is similar to the previous one, with the main difference being the selection of age-based subgroup analysis. The age cutoff is set at 50 years. Interestingly, when the age is set to 50, the total number of case reports for patients using hydroxychloroquine is nearly equal for those older and younger than 50 years.</p>
<p>From the results (<a href="#F5" class="usa-link">Figure 5</a>), we observe that among the 7 ADRs of interest, only hypokalemia is more likely to occur in younger patients, while other cardiac and retinal ADRs tend to occur more frequently in older patients. Specifically, retinal-related ADRs associated with hydroxychloroquine are more prevalent in the older age group, for example, retinopathy (4.2-fold in older than younger people; <em>z</em> test <em><em>P</em></em>
<em>value</em><em>&lt;</em><em>.0</em>01) and visual field defect (4.86-fold in older than younger people; <em>z</em> test <em><em>P</em></em>
<em>value</em><em>&lt;</em><em>.0</em>01). This trend aligns with the findings in the 2024 study by Jorge et al [<a href="#R35" class="usa-link" aria-describedby="R35">35</a>], even though they divided the data at 45 years.</p>
<figure class="fig xbox font-sm" id="F5"><h4 class="obj_head">Figure 5. Assessment of the age-specific risk of hydroxychloroquine on retinopathy, cardiomyopathy, and hypokalemia. Shown is the forest plot comparing the adverse drug reactions (ADRs) of interest between hydroxychloroquine and other drug groups, subgrouped by age (age split set to 50 years). The black diamonds indicate the log2-transformed reporting odds ratios (RORs), and the green lines represent the corresponding log2-transformed 95% CIs. TR: target reaction.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c837/12312990/876ad82c8941/formative-v9-e71519-g005.jpg" loading="lazy" height="421" width="733" alt="Figure 5."></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>Regarding cardiac issues, while some studies suggest that age is not related to cardiac problems in hydroxychloroquine users [<a href="#R38" class="usa-link" aria-describedby="R38">38</a>], analysis of the latest FAERS database indicates that age does indeed influence the occurrence of cardiac-related ADRs, such as cardiomyopathy, with a 7.85-fold higher incidence in older patients compared to younger ones (<em>z</em> test <em><em>P</em></em>
<em>value </em><em>&lt;</em><em>.0</em>01). This suggests that age, a well-established factor in drug-related adverse effects, also plays a significant role in the incidence of cardiac issues with hydroxychloroquine. At the same time, the fact that hydroxychloroquine significantly tends to cause hypokalemia in individuals younger than 50 years also warrants the attention of researchers.</p>
<p>In addition, we conducted an age-based subgroup analysis of the top 10 most frequently reported ADRs potentially representing ADRs for Paxlovid. The ROR differences between ≥50 and &lt;50 year subgroups for these ADRs were all less than 1.5 times (Figure S4 in <a href="#SAP1" class="usa-link">Multimedia Appendix 1</a>), suggesting that age differences have minimal impact on the occurrence of these ADRs.</p></section><section id="s3-7"><h3 class="pmc_sec_title">Website Evaluation</h3>
<p>To further evaluate the functionality and effectiveness of our website, we used 2 main approaches during the assessment process. First, we conducted internal evaluations through regular group meetings, where students tested the website’s drug ADR analysis functions. They also engaged in discussions to compare the analysis results with real-world reports, refining the analysis process to ensure that the results closely reflected actual ADRs. Second, 13 clinical staff members, including pharmacists, physicians, anesthesiologists, and technicians from institutions such as the Beijing Friendship Hospital, Beijing Tongren Hospital, Peking Union Medical College Hospital, Rizhao Central Hospital, and Rizhao Maternal and Child Health Hospital, participated as volunteers from November 2024 to January 2025 (<a href="#T1" class="usa-link">Table 1</a>) to evaluate the Visdrugs website. With their medical background and extensive clinical experience, they provided invaluable feedback after using the website, contributing to the development of the site and ensuring that it serves its purpose in ADR analysis effectively.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">Table 1.  A list of clinical staff members who participated in evaluating the website.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="bottom" rowspan="1" colspan="1">Office unit</th>
<th valign="bottom" rowspan="1" colspan="1">Date of participation</th>
<th valign="bottom" rowspan="1" colspan="1">Form of participation</th>
<th valign="bottom" rowspan="1" colspan="1">Job title</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University</td>
<td valign="top" align="center" rowspan="1" colspan="1">November 22, 2024</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Licensed pharmacist, senior pharmacist</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Otolaryngology, Beijing Friendship Hospital, Capital Medical University</td>
<td valign="top" align="center" rowspan="1" colspan="1">November 22, 2024</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Associate chief physician</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Neurology, Beijing Tongren Hospital,<br>Capital Medical University</td>
<td valign="top" align="center" rowspan="1" colspan="1">December 19, 2024</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Associate chief physician</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Neurology,<br>Peking Union Medical College Hospital</td>
<td valign="top" align="center" rowspan="1" colspan="1">December 19, 2024</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Associate chief physician</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Social Health, Rizhao Maternal and Child Health Hospital, Shandong Province</td>
<td valign="top" align="center" rowspan="1" colspan="1">January 03, 2024</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Director of the department, associate chief technician</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Blood Transfusion, Rizhao Central Hospital, Shandong Province</td>
<td valign="top" align="center" rowspan="1" colspan="1">January 03, 2024</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Director of the department, associate chief technician</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Pharmacy, Rizhao Central Hospital, Shandong Province</td>
<td valign="top" align="center" rowspan="1" colspan="1">January 15, 2024</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Director of the department, associate chief pharmacist</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Pharmacy, Rizhao Central Hospital, Shandong Province</td>
<td valign="top" align="center" rowspan="1" colspan="1">January 15, 2024</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Attending pharmacist</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Pharmacy, Rizhao Central Hospital, Shandong Province</td>
<td valign="top" align="center" rowspan="1" colspan="1">January 15, 2024</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Pharmacist</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Pharmacy, Rizhao Central Hospital, Shandong Province</td>
<td valign="top" align="center" rowspan="1" colspan="1">January 15, 2024</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Pharmacist</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of General Surgery, Rizhao Central Hospital, Shandong Province</td>
<td valign="top" align="center" rowspan="1" colspan="1">January 15, 2024</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Director of the department, chief physician</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Oncology, Rizhao Central Hospital,<br>Shandong Province</td>
<td valign="top" align="center" rowspan="1" colspan="1">January 15, 2024</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Director of the department, associate chief physician</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Anesthesiology, Rizhao Central Hospital, Shandong Province</td>
<td valign="top" align="center" rowspan="1" colspan="1">January 15, 2024</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Deputy director of the department, associate chief anesthesiologist</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Internal Medicine, Urumqi Traditional Chinese Medicine Hospital</td>
<td valign="top" align="center" rowspan="1" colspan="1">January 16, 2025</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Attending doctor</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Reproduction, First Affiliated Hospital of Xinjiang Medical University</td>
<td valign="top" align="center" rowspan="1" colspan="1">January 20, 2025</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Attending doctor</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Department of Hepatology, Autonomous Region People’s Hospital</td>
<td valign="top" align="center" rowspan="1" colspan="1">20 January, 2025</td>
<td valign="top" rowspan="1" colspan="1">Website test and online discussion</td>
<td valign="top" rowspan="1" colspan="1">Attending doctor</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<section id="s4-1"><h3 class="pmc_sec_title">Overview</h3>
<p>The FDA FAERS serves as a valuable resource for identifying potential safety concerns associated with drugs and has been widely used in various studies to monitor and analyze drug-related adverse effects [<a href="#R4" class="usa-link" aria-describedby="R4">4</a>,<a href="#R5" class="usa-link" aria-describedby="R5">5</a>,<a href="#R20" class="usa-link" aria-describedby="R20">20</a>,<a href="#R39" class="usa-link" aria-describedby="R39">39</a>]. Despite the wealth of data available in FAERS, its vast size makes data utilization heavily reliant on bioinformatics technologies. While platforms like VigiAccess and OpenVigil FDA have made significant strides in simplifying the data retrieval process [<a href="#R16" class="usa-link" aria-describedby="R16">16</a>,<a href="#R18" class="usa-link" aria-describedby="R18">18</a>], they still present notable limitations in analytical flexibility and usability for non-expert users. VigiAccess allows users to explore ADR reports for individual drugs with summary statistics such as geographical distribution, gender, and age, but it lacks functionality for analyzing the influence of demographic factors on specific ADRs or for conducting comparative analyses across multiple drugs. OpenVigil FDA supports disproportionality analysis (eg, ROR, proportional reporting ratio) based on FAERS data and allows basic filtering, yet it does not provide flexible subgroup analyses or direct comparison of ADR profiles between drugs in an integrated, user-friendly environment.</p>
<p>To overcome these limitations, we developed VisDrugs, a web-based platform designed to facilitate comprehensive and intuitive ADR analysis for clinicians and researchers. VisDrugs uses an automated, standardized data processing workflow to clean and structure FAERS data using consistent nomenclatures (MedDRA PTs for ADRs and active substance names for drugs). Beyond basic retrieval and disproportionality analysis, VisDrugs offers unique capabilities, including flexible subgroup analysis by gender and age, as well as side-by-side comparison of ADR profiles across 2 drugs—features not available in existing public platforms. These advanced yet accessible functionalities aim to empower health care professionals and researchers to perform more nuanced and clinically relevant evaluations of drug safety without requiring extensive bioinformatics expertise.</p>
<p>From the examples provided in this study, we can see that the ADRs for COVID-19 drug Paxlovid and anti-malarial drug hydroxychloroquine obtained from the VisDrugs platform are highly consistent with those reported in previous studies. For Paxlovid, we primarily observed ADEs related to its use in treating COVID-19, which highlights the importance of distinguishing between ADRs related to the drug itself and those associated with the disease being treated. For hydroxychloroquine, the platform not only confirmed the commonly reported retinal and cardiac adverse effects, but through subgroup analysis, we also identified that retinotoxicity, retinopathy, and cardiomyopathy tend to occur more frequently in females and in individuals aged 50 years or older. These findings align with results from epidemiological studies and previous FAERS analyses [<a href="#R30" class="usa-link" aria-describedby="R30">30-33</a>,<a href="#R31" class="usa-link" aria-describedby="R31">35</a>,<a href="#R32" class="usa-link" aria-describedby="R32">38</a>,<a href="#R33" class="usa-link" aria-describedby="R33">undefined</a>,<a href="#R35" class="usa-link" aria-describedby="R35">undefined</a>,<a href="#R38" class="usa-link" aria-describedby="R38">undefined</a>], demonstrating the accuracy and practical utility of the platform’s ADR analysis functionality.</p>
<p>Additionally, when analyzing the ADRs of an effective drug like Paxlovid [<a href="#R40" class="usa-link" aria-describedby="R40">40</a>], the top ADRs often include many reactions related to its intended indication, and the ROR confirms that these indication-related ADRs are indeed associated with Paxlovid usage. In contrast, when analyzing a drug with strong side effects, such as hydroxychloroquine [<a href="#R41" class="usa-link" aria-describedby="R41">41</a>], many of the top ADRs are non-indication related, and ROR shows that these non-indication ADRs are associated with hydroxychloroquine use. This suggests that the number of indication-related versus non-indication-related ADRs in the top drug usage-relevant ADRs, along with the severity comparison between them, may help evaluate the suitability of a drug. It can be inferred that when the severity of a drug’s side effects does not exceed the severity of its indication, the indication-related ADRs are more likely to catch the attention of the reporters, and thus, most ADRs will be related to the drug’s intended use. However, if a drug’s side effects are so severe that they overshadow the indication, reporters are more likely to focus on reporting these non-indication-related ADRs. For example, in the case of hydroxychloroquine, where the ADR analysis reveals a lack of indication-related ADRs and the drug’s adverse effects lead to severe outcomes, this may indicate that the drug is not suitable for treating that disease.</p></section><section id="s4-2"><h3 class="pmc_sec_title">Limitations and Future Perspectives</h3>
<p>While the development of the VisDrugs platform fills a gap in the existing FAERS analysis tools by offering 1-click visualization of ADR data, it does have some limitations. First, regarding the data source, VisDrugs relies primarily on FAERS data, which are collected through voluntary reports from health care professionals and others. Voluntary reporting bias is a well-known limitation of spontaneous reporting systems such as FAERS. Underreporting is common, particularly for known or less severe ADRs, whereas overreporting may occur following media attention or regulatory actions. Additionally, reporting patterns differ between health care professionals and patients. While health care professional reports are generally more clinically detailed and accurate, patient reports may be broader but less specific. Although VisDrugs enhances data reliability by focusing exclusively on reports submitted by health care professionals, addressing the impact of underreporting and overreporting remains an important challenge for future work. From an analytical perspective, the platform currently provides ADR frequency pie charts and ROR forest plots for analyzing 1 or 2 drugs. While these are useful, more advanced visualization functions are still in development. The platform continues to need optimization and upgrading based on user feedback. Moreover, the current version does not integrate in-depth biological information, such as molecular mechanisms or drug-target interactions, which would further enhance the platform’s utility and depth of analysis.</p>
<p>Additionally, this study did not include a formal usability or performance evaluation of the VisDrugs platform. Structured evaluation studies (eg, user usability testing, performance benchmarking, and accuracy validation) are planned as part of future work to further validate and refine the system.</p>
<p>Looking ahead, we plan to expand the capabilities of the VisDrugs platform by adding more advanced visualization features, offering users the ability to specify the year for analysis, and enabling subgroup analysis based on factors like geographical location. We also aim to incorporate information on known drug indications, molecular targets, and links to ADR annotations to improve the platform’s readability and usability. Furthermore, we envision integrating artificial intelligence technologies, such as machine learning models, to assist in ADR calculation or to use predictive models to interpret user-generated visualized results. These improvements will enhance the efficiency of drug safety evaluations.</p></section><section id="s4-3"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Visdrugs offers a highly streamlined and user-friendly platform for analyzing ADRs, bridging the gap between raw FAERS data and actionable insights into drug safety. What this website focuses on is transforming raw data into accessible and systematic knowledge by establishing a comprehensive analytical platform. This enables medical researchers to efficiently access post-marketing drug safety information without spending time on bioinformatics analyses or coding, allowing them to focus on evaluating the ADR profiles of different drugs. By doing so, VisDrugs contributes to advancing the assessment and monitoring of post-marketing drug safety.</p>
<p>Using the computational methods integrated into this platform, our previous study has already evaluated the pregnancy safety profiles of 2 hepatitis B antiviral drugs, adefovir and entecavir [<a href="#R39" class="usa-link" aria-describedby="R39">39</a>]. Since then, we have further enhanced the platform’s capabilities. Now, it not only supports the analysis of the most common ADRs of individual drugs and the comparison of the toxicity profiles of 2 drug groups, but also enables subgroup analyses based on sex and age. This allows users to investigate the influence of demographic factors on drug safety, providing deeper insights into the differential effects of ADRs.</p>
<p>As demonstrated in our examples, VisDrugs significantly accelerates the process of comprehensive ADR evaluation. In just minutes, users can perform an in-depth assessment of a drug’s safety profile, uncover patterns of ADRs across different demographic groups, and explore the impact of specific factors such as age and sex. This remarkable efficiency makes VisDrugs a powerful tool for advancing drug safety evaluation, improving our ability to monitor, understand, and mitigate ADRs in diverse populations.</p></section></section><section id="s5"><h2 class="pmc_sec_title">Supplementary material</h2>
<section class="sm xbox font-sm" id="SAP1"><div class="caption p"><span>Multimedia Appendix 1. Supplementary figures (Figures S1-S4).</span></div>
<div class="media p" id="d67e1313">
<div class="caption">
<a href="/articles/instance/12312990/bin/formative-v9-e71519-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">formative-v9-e71519-s001.docx</a><sup> (674.7KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.2196/71519</div>
</div></section><section class="sm xbox font-sm" id="SCHL1"><div class="caption p"><span>Checklist 1. Software/Tools Papers checklist.</span></div>
<div class="media p" id="d67e1320">
<div class="caption">
<a href="/articles/instance/12312990/bin/formative-v9-e71519-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">formative-v9-e71519-s002.docx</a><sup> (14.2KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.2196/71519</div>
</div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>This work was supported by the Ministry of Science and Technology of the People’s Republic of China (grant 2020YFA0907500), the National Natural Science Foundation of China [grants 22021003, 22476209, and 22193052], the Science and Technology Program of Tongzhou District of Beijing (WS2025054), the Strategic Priority Research Program of the Chinese Academy of Sciences (grant XDB0750300), Beijing Municipal Natural Science Foundation (funding number IS23120), and Beijing Overseas Talents Center High-level Foreign Talent Project (funding number C2022001). Some figures were made using Figdraw.</p></section><section id="notes1"><h3>Abbreviations</h3>
<dl class="def-list">
<dt>ADR</dt>
<dd><p>adverse drug reaction</p></dd>
<dt>ASCII</dt>
<dd><p>American Standard Code for Information Interchange</p></dd>
<dt>FAERS</dt>
<dd><p>US Food and Drug Administration Adverse Event Reporting System</p></dd>
<dt>FDA</dt>
<dd><p>US Food and Drug Administration</p></dd>
<dt>MedDRA</dt>
<dd><p>Medical Dictionary for Regulatory Activities</p></dd>
<dt>PT</dt>
<dd><p>preferred term</p></dd>
<dt>ROR</dt>
<dd><p>reporting odds ratio</p></dd>
</dl></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p><strong>Data Availability:</strong> The datasets generated or analyzed during this study are available in the Visdrugs GitHub repository [<a href="#R42" class="usa-link" aria-describedby="R42">42</a>].</p></div>
<div class="fn p" id="fn2"><p><strong>Conflicts of Interest:</strong> None declared.</p></div>
</div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000 Oct 7;356(9237):1255–1259. doi: 10.1016/S0140-6736(00)02799-9. doi. Medline.</cite> [<a href="https://doi.org/10.1016/S0140-6736(00)02799-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11072960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Adverse%20drug%20reactions:%20definitions,%20diagnosis,%20and%20management&amp;author=IR%20Edwards&amp;author=JK%20Aronson&amp;volume=356&amp;issue=9237&amp;publication_year=2000&amp;pages=1255-1259&amp;pmid=11072960&amp;doi=10.1016/S0140-6736(00)02799-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R2">
<span class="label">2.</span><cite>Khan LM. Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay--a systematic review. Eur J Clin Pharmacol. 2013 Dec;69(12):1985–1996. doi: 10.1007/s00228-013-1563-z. doi. Medline.</cite> [<a href="https://doi.org/10.1007/s00228-013-1563-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23955174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Clin%20Pharmacol&amp;title=Comparative%20epidemiology%20of%20hospital-acquired%20adverse%20drug%20reactions%20in%20adults%20and%20children%20and%20their%20impact%20on%20cost%20and%20hospital%20stay--a%20systematic%20review&amp;author=LM%20Khan&amp;volume=69&amp;issue=12&amp;publication_year=2013&amp;pages=1985-1996&amp;pmid=23955174&amp;doi=10.1007/s00228-013-1563-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>Alfirevic A, Pirmohamed M. Genomics of adverse drug reactions. Trends Pharmacol Sci. 2017 Jan;38(1):100–109. doi: 10.1016/j.tips.2016.11.003. doi.</cite> [<a href="https://doi.org/10.1016/j.tips.2016.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27955861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Pharmacol%20Sci&amp;title=Genomics%20of%20adverse%20drug%20reactions&amp;author=A%20Alfirevic&amp;author=M%20Pirmohamed&amp;volume=38&amp;issue=1&amp;publication_year=2017&amp;pages=100-109&amp;pmid=27955861&amp;doi=10.1016/j.tips.2016.11.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>Kass-Hout TA, Xu Z, Mohebbi M, et al.  OpenFDA: an innovative platform providing access to a wealth of FDA’s publicly available data. J Am Med Inform Assoc. 2016 May;23(3):596–600. doi: 10.1093/jamia/ocv153. doi. Medline.</cite> [<a href="https://doi.org/10.1093/jamia/ocv153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4901374/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26644398/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Med%20Inform%20Assoc&amp;title=OpenFDA:%20an%20innovative%20platform%20providing%20access%20to%20a%20wealth%20of%20FDA%E2%80%99s%20publicly%20available%20data&amp;author=TA%20Kass-Hout&amp;author=Z%20Xu&amp;author=M%20Mohebbi&amp;volume=23&amp;issue=3&amp;publication_year=2016&amp;pages=596-600&amp;pmid=26644398&amp;doi=10.1093/jamia/ocv153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Liu H, Yang Q, Li Z, Yan S, Ming S. Systematic analysis of sugammadex-related adverse drug reaction signals using FAERS database. Int J Surg. 2025 Feb 1;111(2):1988–1994. doi: 10.1097/JS9.0000000000002194. doi. Medline.</cite> [<a href="https://doi.org/10.1097/JS9.0000000000002194" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39715164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Surg&amp;title=Systematic%20analysis%20of%20sugammadex-related%20adverse%20drug%20reaction%20signals%20using%20FAERS%20database&amp;author=H%20Liu&amp;author=Q%20Yang&amp;author=Z%20Li&amp;author=S%20Yan&amp;author=S%20Ming&amp;volume=111&amp;issue=2&amp;publication_year=2025&amp;pages=1988-1994&amp;pmid=39715164&amp;doi=10.1097/JS9.0000000000002194&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Küçükosmanoglu A, Scoarta S, Houweling M, et al.  A real-world toxicity atlas shows that adverse events of combination therapies commonly result in additive interactions. Clin Cancer Res. 2024 Apr 15;30(8):1685–1695. doi: 10.1158/1078-0432.CCR-23-0914. doi. Medline.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-23-0914" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11016889/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38597991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=A%20real-world%20toxicity%20atlas%20shows%20that%20adverse%20events%20of%20combination%20therapies%20commonly%20result%20in%20additive%20interactions&amp;author=A%20K%C3%BC%C3%A7%C3%BCkosmanoglu&amp;author=S%20Scoarta&amp;author=M%20Houweling&amp;volume=30&amp;issue=8&amp;publication_year=2024&amp;pages=1685-1695&amp;pmid=38597991&amp;doi=10.1158/1078-0432.CCR-23-0914&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Yu RJ, Krantz MS, Phillips EJ, Stone CA., Jr Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA Adverse Event Reporting System (FAERS) J Allergy Clin Immunol Pract. 2021 Feb;9(2):819–829. doi: 10.1016/j.jaip.2020.09.021. doi. Medline.</cite> [<a href="https://doi.org/10.1016/j.jaip.2020.09.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7870524/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32992044/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Allergy%20Clin%20Immunol%20Pract&amp;title=Emerging%20causes%20of%20drug-induced%20anaphylaxis:%20a%20review%20of%20anaphylaxis-associated%20reports%20in%20the%20FDA%20Adverse%20Event%20Reporting%20System%20(FAERS)&amp;author=RJ%20Yu&amp;author=MS%20Krantz&amp;author=EJ%20Phillips&amp;author=CA%20Stone&amp;volume=9&amp;issue=2&amp;publication_year=2021&amp;pages=819-829&amp;pmid=32992044&amp;doi=10.1016/j.jaip.2020.09.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>Wichelmann TA, Abdulmujeeb S, Ehrenpreis ED. Bevacizumab and gastrointestinal perforations: a review from the FDA Adverse Event Reporting System (FAERS) database. Aliment Pharmacol Ther. 2021 Nov;54(10):1290–1297. doi: 10.1111/apt.16601. doi. Medline.</cite> [<a href="https://doi.org/10.1111/apt.16601" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34499740/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aliment%20Pharmacol%20Ther&amp;title=Bevacizumab%20and%20gastrointestinal%20perforations:%20a%20review%20from%20the%20FDA%20Adverse%20Event%20Reporting%20System%20(FAERS)%20database&amp;author=TA%20Wichelmann&amp;author=S%20Abdulmujeeb&amp;author=ED%20Ehrenpreis&amp;volume=54&amp;issue=10&amp;publication_year=2021&amp;pages=1290-1297&amp;pmid=34499740&amp;doi=10.1111/apt.16601&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Zhou X, Yang G, Zeng X, et al.  Dupilumab and the potential risk of eosinophilic pneumonia: case report, literature review, and FAERS database analysis. Front Immunol. 2023;14:1277734.  doi: 10.3389/fimmu.2023.1277734. doi. Medline.</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1277734" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10801202/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38259470/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Dupilumab%20and%20the%20potential%20risk%20of%20eosinophilic%20pneumonia:%20case%20report,%20literature%20review,%20and%20FAERS%20database%20analysis&amp;author=X%20Zhou&amp;author=G%20Yang&amp;author=X%20Zeng&amp;volume=14&amp;publication_year=2023&amp;pages=1277734&amp;pmid=38259470&amp;doi=10.3389/fimmu.2023.1277734&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Ruiz M, Cocores A, Tosti A, Goadsby PJ, Monteith TS. Alopecia as an emerging adverse event to CGRP monoclonal antibodies: cases series, evaluation of FAERS, and literature review. Cephalalgia. 2023 Feb;43(2):3331024221143538. doi: 10.1177/03331024221143538. doi. Medline.</cite> [<a href="https://doi.org/10.1177/03331024221143538" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36739513/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cephalalgia&amp;title=Alopecia%20as%20an%20emerging%20adverse%20event%20to%20CGRP%20monoclonal%20antibodies:%20cases%20series,%20evaluation%20of%20FAERS,%20and%20literature%20review&amp;author=M%20Ruiz&amp;author=A%20Cocores&amp;author=A%20Tosti&amp;author=PJ%20Goadsby&amp;author=TS%20Monteith&amp;volume=43&amp;issue=2&amp;publication_year=2023&amp;pages=3331024221143538&amp;pmid=36739513&amp;doi=10.1177/03331024221143538&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>Ge W, Chen W, Xie H. Real-world evidence supporting the consensus-driven DILI control compounds list: an analysis of FAERS data. J Hepatol. 2025 Apr;82(4):e204–e205. doi: 10.1016/j.jhep.2024.10.030. doi. Medline.</cite> [<a href="https://doi.org/10.1016/j.jhep.2024.10.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39461595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hepatol&amp;title=Real-world%20evidence%20supporting%20the%20consensus-driven%20DILI%20control%20compounds%20list:%20an%20analysis%20of%20FAERS%20data&amp;author=W%20Ge&amp;author=W%20Chen&amp;author=H%20Xie&amp;volume=82&amp;issue=4&amp;publication_year=2025&amp;pages=e204-e205&amp;pmid=39461595&amp;doi=10.1016/j.jhep.2024.10.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Zhao YC, Li X, Wang CQ, et al.  Unveiling the hidden risks: an update decade-long analysis of abraxane-related adverse events from the FAERS database. Int J Nanomedicine. 2024;19:11847–11858. doi: 10.2147/IJN.S490400. doi. Medline.</cite> [<a href="https://doi.org/10.2147/IJN.S490400" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11572439/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39558918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Nanomedicine&amp;title=Unveiling%20the%20hidden%20risks:%20an%20update%20decade-long%20analysis%20of%20abraxane-related%20adverse%20events%20from%20the%20FAERS%20database&amp;author=YC%20Zhao&amp;author=X%20Li&amp;author=CQ%20Wang&amp;volume=19&amp;publication_year=2024&amp;pages=11847-11858&amp;pmid=39558918&amp;doi=10.2147/IJN.S490400&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Andreaggi CA, Novak EA, Mirabile ME, et al.  Safety concerns reported by consumers, manufacturers and healthcare professionals: a detailed evaluation of opioid-related adverse drug reactions in the FDA database over 15 years. Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1627–1635. doi: 10.1002/pds.5105. doi. Medline.</cite> [<a href="https://doi.org/10.1002/pds.5105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32851782/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacoepidemiol%20Drug%20Saf&amp;title=Safety%20concerns%20reported%20by%20consumers,%20manufacturers%20and%20healthcare%20professionals:%20a%20detailed%20evaluation%20of%20opioid-related%20adverse%20drug%20reactions%20in%20the%20FDA%20database%20over%2015%E2%80%89years&amp;author=CA%20Andreaggi&amp;author=EA%20Novak&amp;author=ME%20Mirabile&amp;volume=29&amp;issue=12&amp;publication_year=2020&amp;pages=1627-1635&amp;pmid=32851782&amp;doi=10.1002/pds.5105&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Maciejewski M, Lounkine E, Whitebread S, et al.  Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets. Elife. 2017 Aug 8;6:e25818.  doi: 10.7554/eLife.25818. doi. Medline.</cite> [<a href="https://doi.org/10.7554/eLife.25818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5548487/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28786378/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=Reverse%20translation%20of%20adverse%20event%20reports%20paves%20the%20way%20for%20de-risking%20preclinical%20off-targets&amp;author=M%20Maciejewski&amp;author=E%20Lounkine&amp;author=S%20Whitebread&amp;volume=6&amp;publication_year=2017&amp;pages=e25818&amp;pmid=28786378&amp;doi=10.7554/eLife.25818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R15">
<span class="label">15.</span><cite>Wang K, Wan M, Wang RS, Weng Z. Opportunities for web-based drug repositioning: searching for potential antihypertensive agents with hypotension adverse events. J Med Internet Res. 2016 Apr 1;18(4):e76.  doi: 10.2196/jmir.4541. doi. Medline.</cite> [<a href="https://doi.org/10.2196/jmir.4541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4833875/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27036325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Internet%20Res&amp;title=Opportunities%20for%20web-based%20drug%20repositioning:%20searching%20for%20potential%20antihypertensive%20agents%20with%20hypotension%20adverse%20events&amp;author=K%20Wang&amp;author=M%20Wan&amp;author=RS%20Wang&amp;author=Z%20Weng&amp;volume=18&amp;issue=4&amp;publication_year=2016&amp;pages=e76&amp;pmid=27036325&amp;doi=10.2196/jmir.4541&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R16">
<span class="label">16.</span><cite>Böhm R, von Hehn L, Herdegen T, et al.  OpenVigil FDA – inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications. PLoS ONE. 2016;11(6):e0157753.  doi: 10.1371/journal.pone.0157753. doi. Medline.</cite> [<a href="https://doi.org/10.1371/journal.pone.0157753" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4915658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27326858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=OpenVigil%20FDA%20%E2%80%93%20inspection%20of%20U.S.%20American%20Adverse%20Drug%20Events%20Pharmacovigilance%20Data%20and%20Novel%20Clinical%20Applications&amp;author=R%20B%C3%B6hm&amp;author=L%20von%20Hehn&amp;author=T%20Herdegen&amp;volume=11&amp;issue=6&amp;publication_year=2016&amp;pages=e0157753&amp;pmid=27326858&amp;doi=10.1371/journal.pone.0157753&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Almenoff JS, Pattishall EN, Gibbs TG, DuMouchel W, Evans SJW, Yuen N. Novel statistical tools for monitoring the safety of marketed drugs. Clin Pharmacol Ther. 2007 Aug;82(2):157–166. doi: 10.1038/sj.clpt.6100258. doi. Medline.</cite> [<a href="https://doi.org/10.1038/sj.clpt.6100258" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17538548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmacol%20Ther&amp;title=Novel%20statistical%20tools%20for%20monitoring%20the%20safety%20of%20marketed%20drugs&amp;author=JS%20Almenoff&amp;author=EN%20Pattishall&amp;author=TG%20Gibbs&amp;author=W%20DuMouchel&amp;author=SJW%20Evans&amp;volume=82&amp;issue=2&amp;publication_year=2007&amp;pages=157-166&amp;pmid=17538548&amp;doi=10.1038/sj.clpt.6100258&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R18">
<span class="label">18.</span><cite>Huang Y, Xu M, Ma X, et al.  Characterizing ADRs of Enfortumab vedotin and Erdafitinib in bladder cancer treatment: a descriptive analysis from WHO-VigiAccess. Front Pharmacol. 2024;15:1503154. doi: 10.3389/fphar.2024.1503154. doi.</cite> [<a href="https://doi.org/10.3389/fphar.2024.1503154" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11659001/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39712492/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Characterizing%20ADRs%20of%20Enfortumab%20vedotin%20and%20Erdafitinib%20in%20bladder%20cancer%20treatment:%20a%20descriptive%20analysis%20from%20WHO-VigiAccess&amp;author=Y%20Huang&amp;author=M%20Xu&amp;author=X%20Ma&amp;volume=15&amp;publication_year=2024&amp;pages=1503154&amp;pmid=39712492&amp;doi=10.3389/fphar.2024.1503154&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Yang R, Yin N, Zhang Y, Faiola F. FAERS analysis. Stem Cell Toxicology.  [22-07-2025]. <a href="http://sctdb.cn/shiny-server/Visdrugs_v.0.1.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://sctdb.cn/shiny-server/Visdrugs_v.0.1.0/</a> URL. Accessed.</cite>
</li>
<li id="R20">
<span class="label">20.</span><cite>Caldito NG, Shirani A, Salter A, Stuve O. Adverse event profile differences between rituximab and ocrelizumab: findings from the FDA Adverse Event Reporting Database. Mult Scler. 2021 Jun;27(7):1066–1076. doi: 10.1177/1352458520949986. doi. Medline.</cite> [<a href="https://doi.org/10.1177/1352458520949986" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32820687/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mult%20Scler&amp;title=Adverse%20event%20profile%20differences%20between%20rituximab%20and%20ocrelizumab:%20findings%20from%20the%20FDA%20Adverse%20Event%20Reporting%20Database&amp;author=NG%20Caldito&amp;author=A%20Shirani&amp;author=A%20Salter&amp;author=O%20Stuve&amp;volume=27&amp;issue=7&amp;publication_year=2021&amp;pages=1066-1076&amp;pmid=32820687&amp;doi=10.1177/1352458520949986&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):519–523. doi: 10.1002/pds.1001. doi. Medline.</cite> [<a href="https://doi.org/10.1002/pds.1001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15317031/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacoepidemiol%20Drug%20Saf&amp;title=The%20reporting%20odds%20ratio%20and%20its%20advantages%20over%20the%20proportional%20reporting%20ratio&amp;author=KJ%20Rothman&amp;author=S%20Lanes&amp;author=ST%20Sacks&amp;volume=13&amp;issue=8&amp;publication_year=2004&amp;pages=519-523&amp;pmid=15317031&amp;doi=10.1002/pds.1001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Liu J, Cao R, Xu M, et al.  Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6:16.  doi: 10.1038/s41421-020-0156-0. doi. Medline.</cite> [<a href="https://doi.org/10.1038/s41421-020-0156-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7078228/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32194981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Discov&amp;title=Hydroxychloroquine,%20a%20less%20toxic%20derivative%20of%20chloroquine,%20is%20effective%20in%20inhibiting%20SARS-CoV-2%20infection%20in%20vitro&amp;author=J%20Liu&amp;author=R%20Cao&amp;author=M%20Xu&amp;volume=6&amp;publication_year=2020&amp;pages=16&amp;pmid=32194981&amp;doi=10.1038/s41421-020-0156-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>Manjaly Thomas ZR, Leuppi-Taegtmeyer A, Jamiolkowski D, et al.  Emerging treatments in COVID-19: adverse drug reactions including drug hypersensitivities. J Allergy Clin Immunol. 2020 Oct;146(4):786–789. doi: 10.1016/j.jaci.2020.07.008. doi. Medline.</cite> [<a href="https://doi.org/10.1016/j.jaci.2020.07.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7833501/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32710973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Allergy%20Clin%20Immunol&amp;title=Emerging%20treatments%20in%20COVID-19:%20adverse%20drug%20reactions%20including%20drug%20hypersensitivities&amp;author=ZR%20Manjaly%20Thomas&amp;author=A%20Leuppi-Taegtmeyer&amp;author=D%20Jamiolkowski&amp;volume=146&amp;issue=4&amp;publication_year=2020&amp;pages=786-789&amp;pmid=32710973&amp;doi=10.1016/j.jaci.2020.07.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Tan B, Zhang X, Ansari A, et al.  Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model. Science. 2024 Mar 29;383(6690):1434–1440. doi: 10.1126/science.adm9724. doi. Medline.</cite> [<a href="https://doi.org/10.1126/science.adm9724" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12178660/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38547259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Design%20of%20a%20SARS-CoV-2%20papain-like%20protease%20inhibitor%20with%20antiviral%20efficacy%20in%20a%20mouse%20model&amp;author=B%20Tan&amp;author=X%20Zhang&amp;author=A%20Ansari&amp;volume=383&amp;issue=6690&amp;publication_year=2024&amp;pages=1434-1440&amp;pmid=38547259&amp;doi=10.1126/science.adm9724&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>Schillings J, Ramos-Guzmán CA, Ruiz-Pernía JJ, Tuñón I. Pomotrelvir and Nirmatrelvir binding and reactivity with SARS-CoV-2 main protease: implications for resistance mechanisms from computations. Angew Chem Int Ed Engl. 2024 Oct 1;63(40):e202409527.  doi: 10.1002/anie.202409527. doi. Medline.</cite> [<a href="https://doi.org/10.1002/anie.202409527" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38959351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Angew%20Chem%20Int%20Ed%20Engl&amp;title=Pomotrelvir%20and%20Nirmatrelvir%20binding%20and%20reactivity%20with%20SARS-CoV-2%20main%20protease:%20implications%20for%20resistance%20mechanisms%20from%20computations&amp;author=J%20Schillings&amp;author=CA%20Ramos-Guzm%C3%A1n&amp;author=JJ%20Ruiz-Pern%C3%ADa&amp;author=I%20Tu%C3%B1%C3%B3n&amp;volume=63&amp;issue=40&amp;publication_year=2024&amp;pages=e202409527&amp;pmid=38959351&amp;doi=10.1002/anie.202409527&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R26">
<span class="label">26.</span><cite>Pavan M, Bolcato G, Bassani D, Sturlese M, Moro S. Supervised Molecular Dynamics (SuMD) insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332. J Enzyme Inhib Med Chem. 2021 Dec;36(1):1646–1650. doi: 10.1080/14756366.2021.1954919. doi. Medline.</cite> [<a href="https://doi.org/10.1080/14756366.2021.1954919" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8300928/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34289752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Enzyme%20Inhib%20Med%20Chem&amp;title=Supervised%20Molecular%20Dynamics%20(SuMD)%20insights%20into%20the%20mechanism%20of%20action%20of%20SARS-CoV-2%20main%20protease%20inhibitor%20PF-07321332&amp;author=M%20Pavan&amp;author=G%20Bolcato&amp;author=D%20Bassani&amp;author=M%20Sturlese&amp;author=S%20Moro&amp;volume=36&amp;issue=1&amp;publication_year=2021&amp;pages=1646-1650&amp;pmid=34289752&amp;doi=10.1080/14756366.2021.1954919&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>Hoang T. Systematic review and meta-analysis of factors associated with re-positive viral RNA after recovery from COVID-19. J Med Virol. 2021 Apr;93(4):2234–2242. doi: 10.1002/jmv.26648. doi. Medline.</cite> [<a href="https://doi.org/10.1002/jmv.26648" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33135788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Virol&amp;title=Systematic%20review%20and%20meta-analysis%20of%20factors%20associated%20with%20re-positive%20viral%20RNA%20after%20recovery%20from%20COVID-19&amp;author=T%20Hoang&amp;volume=93&amp;issue=4&amp;publication_year=2021&amp;pages=2234-2242&amp;pmid=33135788&amp;doi=10.1002/jmv.26648&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Elzein F, Ibrahim A, Alshahrani F, et al.  Reinfection, recurrence, or delayed presentation of COVID-19? Case series and review of the literature. J Infect Public Health. 2021 Apr;14(4):474–477. doi: 10.1016/j.jiph.2021.01.002. doi. Medline.</cite> [<a href="https://doi.org/10.1016/j.jiph.2021.01.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7834000/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33743368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Infect%20Public%20Health&amp;title=Reinfection,%20recurrence,%20or%20delayed%20presentation%20of%20COVID-19?%20Case%20series%20and%20review%20of%20the%20literature&amp;author=F%20Elzein&amp;author=A%20Ibrahim&amp;author=F%20Alshahrani&amp;volume=14&amp;issue=4&amp;publication_year=2021&amp;pages=474-477&amp;pmid=33743368&amp;doi=10.1016/j.jiph.2021.01.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>Li M, Zhang QS, Liu XL, Wang HL, Liu W. Adverse events associated with Nirmatrelvir/Ritonavir: a pharmacovigilance analysis based on FAERS. Pharmaceuticals (Basel) 2022 Nov 24;15(12):1455.  doi: 10.3390/ph15121455. doi. Medline.</cite> [<a href="https://doi.org/10.3390/ph15121455" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9786063/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36558906/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals%20(Basel)&amp;title=Adverse%20events%20associated%20with%20Nirmatrelvir/Ritonavir:%20a%20pharmacovigilance%20analysis%20based%20on%20FAERS&amp;author=M%20Li&amp;author=QS%20Zhang&amp;author=XL%20Liu&amp;author=HL%20Wang&amp;author=W%20Liu&amp;volume=15&amp;issue=12&amp;publication_year=2022&amp;pages=1455&amp;pmid=36558906&amp;doi=10.3390/ph15121455&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Melles RB, Jorge AM, Marmor MF, et al.  Hydroxychloroquine dose and risk for incident retinopathy: a cohort study. Ann Intern Med. 2023 Feb;176(2):166–173. doi: 10.7326/M22-2453. doi. Medline.</cite> [<a href="https://doi.org/10.7326/M22-2453" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36645889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Intern%20Med&amp;title=Hydroxychloroquine%20dose%20and%20risk%20for%20incident%20retinopathy:%20a%20cohort%20study&amp;author=RB%20Melles&amp;author=AM%20Jorge&amp;author=MF%20Marmor&amp;volume=176&amp;issue=2&amp;publication_year=2023&amp;pages=166-173&amp;pmid=36645889&amp;doi=10.7326/M22-2453&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Kim J, Kim KE, Kim JH, Ahn SJ. Practice patterns of screening for hydroxychloroquine retinopathy in South Korea. JAMA Netw Open. 2023 May 1;6(5):e2314816.  doi: 10.1001/jamanetworkopen.2023.14816. doi.</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2023.14816" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10208143/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37219905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Netw%20Open&amp;title=Practice%20patterns%20of%20screening%20for%20hydroxychloroquine%20retinopathy%20in%20South%20Korea&amp;author=J%20Kim&amp;author=KE%20Kim&amp;author=JH%20Kim&amp;author=SJ%20Ahn&amp;volume=6&amp;issue=5&amp;publication_year=2023&amp;pages=e2314816&amp;pmid=37219905&amp;doi=10.1001/jamanetworkopen.2023.14816&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>Chatre C, Roubille F, Vernhet H, Jorgensen C, Pers YM. Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature. Drug Saf. 2018 Oct;41(10):919–931. doi: 10.1007/s40264-018-0689-4. doi. Medline.</cite> [<a href="https://doi.org/10.1007/s40264-018-0689-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29858838/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Saf&amp;title=Cardiac%20complications%20attributed%20to%20chloroquine%20and%20hydroxychloroquine:%20a%20systematic%20review%20of%20the%20literature&amp;author=C%20Chatre&amp;author=F%20Roubille&amp;author=H%20Vernhet&amp;author=C%20Jorgensen&amp;author=YM%20Pers&amp;volume=41&amp;issue=10&amp;publication_year=2018&amp;pages=919-931&amp;pmid=29858838&amp;doi=10.1007/s40264-018-0689-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R33">
<span class="label">33.</span><cite>Voisin O, Lorc’h E le, Mahé A, et al.  Acute QT interval modifications during hydroxychloroquine-azithromycin treatment in the context of COVID-19 infection. Mayo Clin Proc. 2020 Aug;95(8):1696–1700. doi: 10.1016/j.mayocp.2020.05.005. doi. Medline.</cite> [<a href="https://doi.org/10.1016/j.mayocp.2020.05.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7237942/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32753141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mayo%20Clin%20Proc&amp;title=Acute%20QT%20interval%20modifications%20during%20hydroxychloroquine-azithromycin%20treatment%20in%20the%20context%20of%20COVID-19%20infection&amp;author=O%20Voisin&amp;author=E%20le%20Lorc%E2%80%99h&amp;author=A%20Mah%C3%A9&amp;volume=95&amp;issue=8&amp;publication_year=2020&amp;pages=1696-1700&amp;pmid=32753141&amp;doi=10.1016/j.mayocp.2020.05.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Marquardt K, Albertson TE. Treatment of hydroxychloroquine overdose. Am J Emerg Med. 2001 Sep;19(5):420–424. doi: 10.1053/ajem.2001.25774. doi.</cite> [<a href="https://doi.org/10.1053/ajem.2001.25774" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11555803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Emerg%20Med&amp;title=Treatment%20of%20hydroxychloroquine%20overdose&amp;author=K%20Marquardt&amp;author=TE%20Albertson&amp;volume=19&amp;issue=5&amp;publication_year=2001&amp;pages=420-424&amp;pmid=11555803&amp;doi=10.1053/ajem.2001.25774&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Jorge AM, Melles RB, Marmor MF, Zhou B, Zhang Y, Choi HK. Risk factors for hydroxychloroquine retinopathy and its subtypes. JAMA Netw Open. 2024 May 1;7(5):e2410677.  doi: 10.1001/jamanetworkopen.2024.10677. doi. Medline.</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2024.10677" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11082687/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38722628/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Netw%20Open&amp;title=Risk%20factors%20for%20hydroxychloroquine%20retinopathy%20and%20its%20subtypes&amp;author=AM%20Jorge&amp;author=RB%20Melles&amp;author=MF%20Marmor&amp;author=B%20Zhou&amp;author=Y%20Zhang&amp;volume=7&amp;issue=5&amp;publication_year=2024&amp;pages=e2410677&amp;pmid=38722628&amp;doi=10.1001/jamanetworkopen.2024.10677&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R36">
<span class="label">36.</span><cite>Goldman A, Bomze D, Dankner R, et al.  Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: a comprehensive pharmacovigilance analysis of pre-COVID-19 reports. Br J Clin Pharmacol. 2021 Mar;87(3):1432–1442. doi: 10.1111/bcp.14546. doi. Medline.</cite> [<a href="https://doi.org/10.1111/bcp.14546" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32964535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Clin%20Pharmacol&amp;title=Cardiovascular%20adverse%20events%20associated%20with%20hydroxychloroquine%20and%20chloroquine:%20a%20comprehensive%20pharmacovigilance%20analysis%20of%20pre-COVID-19%20reports&amp;author=A%20Goldman&amp;author=D%20Bomze&amp;author=R%20Dankner&amp;volume=87&amp;issue=3&amp;publication_year=2021&amp;pages=1432-1442&amp;pmid=32964535&amp;doi=10.1111/bcp.14546&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R37">
<span class="label">37.</span><cite>Rafaniello C, Gaio M, Zinzi A, et al.  Disentangling a thorny issue: myocarditis and pericarditis post COVID-19 and following mRNA COVID-19 vaccines. Pharmaceuticals (Basel) 2022 Apr 25;15(5):525.  doi: 10.3390/ph15050525. doi. Medline.</cite> [<a href="https://doi.org/10.3390/ph15050525" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9145505/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35631352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals%20(Basel)&amp;title=Disentangling%20a%20thorny%20issue:%20myocarditis%20and%20pericarditis%20post%20COVID-19%20and%20following%20mRNA%20COVID-19%20vaccines&amp;author=C%20Rafaniello&amp;author=M%20Gaio&amp;author=A%20Zinzi&amp;volume=15&amp;issue=5&amp;publication_year=2022&amp;pages=525&amp;pmid=35631352&amp;doi=10.3390/ph15050525&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R38">
<span class="label">38.</span><cite>Pinheiro MM, Pileggi GS, Kakehasi AM, et al.  Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort. Clin Exp Rheumatol. 2022 Jul;40(7):1258–1266. doi: 10.55563/clinexprheumatol/67oyux. doi. Medline.</cite> [<a href="https://doi.org/10.55563/clinexprheumatol/67oyux" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34251312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Exp%20Rheumatol&amp;title=Incidence%20and%20risk%20factors%20for%20moderate/severe%20COVID-19%20in%20rheumatic%20diseases%20patients%20on%20hydroxychloroquine:%20a%2024-week%20prospective%20cohort&amp;author=MM%20Pinheiro&amp;author=GS%20Pileggi&amp;author=AM%20Kakehasi&amp;volume=40&amp;issue=7&amp;publication_year=2022&amp;pages=1258-1266&amp;pmid=34251312&amp;doi=10.55563/clinexprheumatol/67oyux&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R39">
<span class="label">39.</span><cite>Yang R, Yin N, Zhao Y, et al.  Adverse events during pregnancy associated with entecavir and adefovir: new insights from a real-world analysis of cases reported to FDA adverse event reporting system. Front Pharmacol. 2021;12:772768.  doi: 10.3389/fphar.2021.772768. doi. Medline.</cite> [<a href="https://doi.org/10.3389/fphar.2021.772768" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8762051/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35046808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Adverse%20events%20during%20pregnancy%20associated%20with%20entecavir%20and%20adefovir:%20new%20insights%20from%20a%20real-world%20analysis%20of%20cases%20reported%20to%20FDA%20adverse%20event%20reporting%20system&amp;author=R%20Yang&amp;author=N%20Yin&amp;author=Y%20Zhao&amp;volume=12&amp;publication_year=2021&amp;pages=772768&amp;pmid=35046808&amp;doi=10.3389/fphar.2021.772768&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R40">
<span class="label">40.</span><cite>Harris E. FDA grants full approval to paxlovid, COVID-19 antiviral treatment. JAMA. 2023 Jun 27;329(24):2118. doi: 10.1001/jama.2023.9925. doi.</cite> [<a href="https://doi.org/10.1001/jama.2023.9925" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37285173/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=FDA%20grants%20full%20approval%20to%20paxlovid,%20COVID-19%20antiviral%20treatment&amp;author=E%20Harris&amp;volume=329&amp;issue=24&amp;publication_year=2023&amp;pages=2118&amp;pmid=37285173&amp;doi=10.1001/jama.2023.9925&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R41">
<span class="label">41.</span><cite>Juurlink DN. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. Can Med Assoc J. 2020 Apr 27;192(17):E450–E453. doi: 10.1503/cmaj.200528. doi. Medline.</cite> [<a href="https://doi.org/10.1503/cmaj.200528" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7207200/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32269021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Can%20Med%20Assoc%20J&amp;title=Safety%20considerations%20with%20chloroquine,%20hydroxychloroquine%20and%20azithromycin%20in%20the%20management%20of%20SARS-CoV-2%20infection&amp;author=DN%20Juurlink&amp;volume=192&amp;issue=17&amp;publication_year=2020&amp;pages=E450-E453&amp;pmid=32269021&amp;doi=10.1503/cmaj.200528&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R42">
<span class="label">42.</span><cite>Mrpotatod/visdrugs_v.0.1.0. GitHub.  [22-07-2025]. <a href="https://github.com/mrpotatod/Visdrugs_v.0.1.0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/mrpotatod/Visdrugs_v.0.1.0</a> URL. Accessed.</cite>
</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>Multimedia Appendix 1. Supplementary figures (Figures S1-S4).</span></div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/12312990/bin/formative-v9-e71519-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">formative-v9-e71519-s001.docx</a><sup> (674.7KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.2196/71519</div>
</div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><span>Checklist 1. Software/Tools Papers checklist.</span></div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/12312990/bin/formative-v9-e71519-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">formative-v9-e71519-s002.docx</a><sup> (14.2KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.2196/71519</div>
</div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from JMIR Formative Research are provided here courtesy of <strong>JMIR Publications Inc.</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.2196/71519"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/formative-v9-e71519.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.7 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12312990/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12312990/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12312990%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12312990/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12312990/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12312990/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40743475/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12312990/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40743475/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12312990/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12312990/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="oCDf61VFl1XFvKw2FT0yNi4Ql01Cr9AGQVXwZgutkd1tbzxHk6ug98EXhB7Nfomq">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-B7-tgZZA.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-BLbQGH8u.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-DKf1UY8S.js"></script>
    
    

    </body>
</html>
